CAS: 53267-01-9 - Cibenzoline
Formula:C18H18N2
InChI:InChI=1S/C18H18N2/c1-3-7-14(8-4-1)18(15-9-5-2-6-10-15)13-16(18)17-19-11-12-20-17/h1-10,16H,11-13H2,(H,19,20)
InChI key:InChIKey=IPOBOOXFSRWSHL-UHFFFAOYSA-N
SMILES:N1=C(NCC1)C2CC2(C=3C=CC=CC3)C=4C=CC=CC4
- Synonyms:
- (RS)-Cibenzoline
- (±)-2-(2,2-Diphenylcyclopropyl)-2-imidazoline
- (±)-2-(2,2-Diphenylcyclopropyl)-4,5-dihydro-1H-imidazole
- 1-(2-D2-Imidazolinyl)-2,2-diphenylcyclopropane
- 1H-imidazole, 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-
- 258-453-7
- Cifenline
- Ro 22-7796
- Up 33-901
1H-Imidazole, 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-
CAS:53267-01-9
Formula:
C18H18N2
Purity:
99%
Color and Shape:
Solid
Molecular weight:
262.3489
Ref: IN-DA00I9IC
1mg | 565.00 € | ||
5mg | To inquire | ||
10mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-C-280001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 27 Nov 2024
Ref: 7W-GP1349
Undefined size | To inquire |
Estimated delivery in United States, on Wednesday 27 Nov 2024
Cibenzoline
Controlled ProductCAS:53267-01-9
Applications Cibenzoline acts as a highly active class I antiarrhythmic agent. References Xie, C. et …
Formula:
C18H18N2
Color and Shape:
Neat
Molecular weight:
262.35
Ref: TR-C535723
1mg | 142.00 € | ||
5mg | 511.00 € | ||
10mg | 922.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Cibenzoline
CAS:53267-01-9
Cibenzoline is a drug that is used to diagnose and treat atrial fibrillation. It has …
Formula:
C18H18N2
Purity:
Min. 95%
Molecular weight:
262.35 g/mol
Ref: 3D-DCA26701
25mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Cibenzoline
CAS:53267-01-9
Cibenzoline: antiarrhythmic, blocks KATP channels, minimizes LVPG, useful in hypertrophic cardiomyopathy studies.
Formula:
C18H18N2
Color and Shape:
Solid
Molecular weight:
262.35
Ref: TM-T60428
25mg | 1,249.00 € | ||
50mg | 1,623.00 € | ||
100mg | 2,434.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025